{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_4816", "batch_size": 200, "batch_pos": 102, "statement_text": "Moderna shares MRNA have jumped 48.7% in the year to date, while the S&P 500 SPX has climbed 10.4%.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "'jumped' and 'climbed' describe stock price trends, not Q2 cues related to the threat.", "method": "llm_batch", "batch_id": "batch_2_8512", "batch_size": 200, "batch_pos": 95, "statement_text": "Moderna shares MRNA have jumped 48.7% in the year to date, while the S&P 500 SPX has climbed 10.4%.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "This segment reports on financial metrics ('shares MRNA have jumped'), which is excluded by rule 6.", "method": "llm_batch", "batch_id": "batch_3_19416", "batch_size": 200, "batch_pos": 88, "statement_text": "Moderna shares MRNA have jumped 48.7% in the year to date, while the S&P 500 SPX has climbed 10.4%.", "article_id": 1648}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_11940", "batch_size": 200, "batch_pos": 87, "statement_text": "Moderna shares MRNA have jumped 48.7% in the year to date, while the S&P 500 SPX has climbed 10.4%.", "article_id": 1648}
{"Q": 5, "answer": "no", "rationale": "The segment reports stock price movement, which is not a calming cue about the disease.", "method": "llm_batch", "batch_id": "batch_5_12384", "batch_size": 200, "batch_pos": 86, "statement_text": "Moderna shares MRNA have jumped 48.7% in the year to date, while the S&P 500 SPX has climbed 10.4%.", "article_id": 1648}
{"Q": 6, "answer": "no", "rationale": "No minimiser or scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_6968", "batch_size": 200, "batch_pos": 74, "statement_text": "Moderna shares MRNA have jumped 48.7% in the year to date, while the S&P 500 SPX has climbed 10.4%.", "article_id": 1648}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_6192", "batch_size": 200, "batch_pos": 64, "statement_text": "Moderna shares MRNA have jumped 48.7% in the year to date, while the S&P 500 SPX has climbed 10.4%.", "article_id": 1648}
{"Q": 8, "answer": "no", "rationale": "The segment describes stock market performance, not capability or preparedness.", "method": "llm_batch", "batch_id": "batch_8_12124", "batch_size": 200, "batch_pos": 29, "statement_text": "Moderna shares MRNA have jumped 48.7% in the year to date, while the S&P 500 SPX has climbed 10.4%.", "article_id": 1648}
{"Q": 9, "answer": "yes", "rationale": "Reports stock prices using standard verbs ('have jumped 48.7%', 'has climbed 10.4%') factually.", "method": "llm_batch", "batch_id": "batch_9_18136", "batch_size": 200, "batch_pos": 145, "statement_text": "Moderna shares MRNA have jumped 48.7% in the year to date, while the S&P 500 SPX has climbed 10.4%.", "article_id": 1648}
